XENE
Xenon Pharmaceuticals Inc. · Healthcare
EVP, Strategy, Innovation Sherrington Robin sold $2.5M of Xenon Pharmaceuticals Inc.
Sold$2,499,023
$38.31Price
65,231Shares
−80%Stake
What XENE did after the filing
- The stock from Fri, Sep 2 close, $39.00
- −10.9%
- S&P 500, same days
- −6.1%
Measured over 30 trading days, to the Oct 17 close.
Traded Wed, Aug 31. Filed Fri, Sep 2, 12:27 PM ET, during the session. Returns use the Sep 2 close and the Oct 17 close. Not investment advice.